← Back to Newsletter Archive

Greetings!

Welcome to the QPS Pharmacology Newsletter


Explore how the QPS ulcerative colitis model can support your drug development program, and learn about our mRNA capabilities. Then catch up on the latest scientific insights from the QPS blog.

Acute DSS-induced Ulcerative Colitis Model

Evaluate therapeutic activity in acute intestinal inflammation with QPS’s dextran sulphate sodium (DSS)-induced colitis model. Established by administering DSS in drinking water, this widely used murine model supports preclinical evaluation of test articles for the treatment of ulcerative colitis (UC).


Incorporating this model into your pharmacology program can help characterize treatment effects, compare candidate compounds, and inform dose selection for subsequent studies.

Discover More Pharmacology Models at QPS

Strengthen Your Gene Therapy Program

Keep your mRNA program moving with strategies to address stability, delivery, and bioanalytical challenges. QPS combines bioanalytical expertise with responsive support to help you generate the data needed for your next development decision.


Read our Bioanalysis of mRNA white paper to explore therapeutic applications, delivery strategies, and analytical approaches, including RT-qPCR, immunoassays, and hybridization HPLC, and their roles in evaluating mRNA therapies.


Explore the White Paper

Bioanalysis of mRNA

Discover the Future of Science on the QPS Blog

Bayesian Statistics in Clinical Trials: Learning From the Past



Could a statistical approach developed more than 250 years ago help make modern clinical trials more efficient and less costly? Bayesian statistics offers...


Two Approaches to Interpreting Clinical Data

Clinical Data Management at QPS

Antibody-Drug Conjugates: Oncology Therapy Developments


The 2026 World Conference on Lung Cancer (WCLC), the biggest annual meeting on lung cancer research, recently wrapped up, and the…


All Eyes on ADC Lung Cancer Studies

Oncology Clinical Trials at QPS

Contact the Experts at QPS


Request a meeting with QPS preclinical, bioanalysis, translational medicine, and/or clinical research subject matter experts today to explore how we can help accelerate your next drug development program.

Visit our website www.qps.com 

or contact us at infopr@qps.com

to start your next study.

Linkedin  Youtube  X  Facebook  

View as Webpage

www.qps.com | infopr@qps.com

We use your email address exclusively for sending QPS newsletters with a special e-mail program. If you no longer wish to receive any mailings, simply use the "unsubscribe" link at the bottom. If you don't unsubscribe, we assume that this consent also applies to the system of the GDPR. (Data protection notice: According to Art. 7 GDPR, the consent can of course also be withdrawn at any time after May 25, 2018.)
← Back to Newsletter Archive